https://de.marketscreener.com/kurs/aktie/BASILEA-PHARMACEUTICA-AG-130199/news/Basilea-erhalt-US-Zulassung-fur-Antibiotikum-Ceftobiprol-46352761/?utm_source=telegram&utm_medium=social&utm_campaign=share